Sveriges mest populära poddar
Motley Fool Money
NäringslivInvestering

DTC Healthcare with 23andMe CEO Anne Wojcicki

26 min•24 april 2022
Genes aren’t always predictive, but understanding them better could dramatically improve our healthcare system. Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe, about her company and why it’s looking to tell you much more than the names of your long-lost relatives. They discuss: - Opportunities in direct-to-consumer healthcare - Creating more personalized medicine - The limits of genetic testing Host: Brian Orelli Guest: Anne Wojcicki Producer: Ricky Mulvey Engineers: Dan Boyd, Brandon Gentry Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av Motley Fool Money

Visa alla avsnitt av Motley Fool Money
The Psychedelic Revolution
•25 min
Hannah Moore on How to Become a Professional Financial Planner
•27 min
AI’s Most Dangerous Moment
•42 min
Will AI Destroy the Software Industry?
•26 min
Why Alphabet is the Winner from Anthropic’s Incredible Growth
•19 min
Breaking Down Jamie Dimon’s Investing Letter
•24 min
Smooth Investing When the Ride is Bumpy
•25 min
The Secret to Out-Innovating the Competition: Inside the Tesla Playbook
•26 min
Which Types of Investments Should You Own and Where Should You Own Them
•33 min
A $2 Trillion IPO & the Space Economy
•42 min

Motley Fool Money med The Motley Fool finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.